An interventional study of air-polishing devices and non-surgical treatment in Peri-implantitis, sponsored by Ordu University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Ordu University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 54 studies in Peri-Implantitis with a site in Turkey — 15 open to participants now, 18 under way, none of them phase 3. Peri-Implantitis · Turkey.
Among the 54 studies in Peri-Implantitis with a site in Turkey, this one is the 11th largest by enrollment of the 26 interventional ones that give a count, is one of 8 that started in 2025, is one of 26 with no phase, and was the 54th registered.
323 studies on the registry are indexed under Peri-Implantitis; 88 are open to participants now.
Browse Peri-Implantitis studies →15 of the 54 studies in Peri-Implantitis with a site in Turkey are open now. Recruiting first, the newest first:
Saglik Bilimleri Universitesi · Sites in Turkey
Ages 18+ · Healthy volunteers
Gazi University · Sites in Turkey
Ages 21–75 · Healthy volunteers
Gazi University · Sites in Turkey
Ages 18–75 · Healthy volunteers
Biruni University · Sites in Turkey
Ages 18+
Recep Tayyip Erdogan University · Sites in Turkey
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 49 Peri-Implantitis studies recruiting now, 27 (55%) set no upper age limit and 9 (18%) stop at 75 or younger; 7 take children under 18; 26 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
54 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 8 started in 2025.
This study's enrollment of 54 is above the median of 40 across 196 interventional studies indexed under Peri-Implantitis.
Median enrollment 50 across the 26 interventional studies, 84 across the 28 observational. Of the 34 that completed or were terminated, 1 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 54 has an industry lead sponsor. The 10 most frequent:
Ordu University is the lead sponsor of 33 studies on the registry; 12 are open to participants now.
Ordu University has 1 study filed under Peri-Implantitis — fewer than ten, so there is no comparison to draw.
7 of the studies in Peri-Implantitis with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06830200Hacettepe UniversityPeri-implantitis Treatment With Chitosan Brush | 2026-12-01 |
| NCT07907900Ankara UniversityDiagnostic Accuracy of Large Language Models for Peri-Implant Marginal Bone Loss on Panoramic Radiographs | 2026-12-31 |
| NCT07785817Medipol UniversityEvaluation of aMMP-8 and IL-1β Levels and Marginal Bone Loss Associated With Peri-Implant Mucositis and Peri-Implantitis in Postmenopausal Women | 2027-02-01 |
| NCT07797127Adiyaman UniversityEvaluation of the Effects of Routine Phase I Periodontal Therapy on Clinical Parameters and Levels of Gremlin-1, CTHRC1, and Tenascin-C in Gingival Crevicular Fluid and Peri-Implant Sulcular Fluid in Individuals With Periodontitis and Peri-Implantitis | 2027-03-01 |
| NCT07471386Gazi UniversityAdjunctive Keratinized Mucosa Augmentation in Peri-Implantitis | 2027-04-01 |
Add all 7 to your calendar (.ics) → With an account.
Among the 54 studies in Peri-Implantitis with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aimed to assess the effect of subgingival air polishing with erythritol as an adjunctive treatment in the non-surgical treatment of peri-implantitis on clinical parameters and inflammatory cytokine levels (IL-1β, TNF-α, IL-8, and IL-36) peri-implant crevicular fluid (PICF) among patients with peri-implantitis.
The aim of this study was to evaluate the effects of adjunctive use of air-polishing devices (APDs) to non-surgical treatment (NST) on clinical parameters and the levels of IL-1β, TNF-α, IL-8, and IL-36 in peri-implant crevicular fluid (PICF) of patients with peri-implantitis. Fifty-four participants (54 implants) with functional implants (≥1 year) were included in a randomized, parallel group clinical trial. The control group consisted of 19 individuals with healthy implants, while the test group comprised 35 patients with peri-implantitis; 18 patients were randomly assigned to receive treatment with APDs (Airflow Master Piezon®, EMS) +NST, and another 17 patients were treated with NST using only titanium curettes. Clinical parameters (plaque index, gingival index, bleeding on probing, probing pocket depth, radiographic bone level, suppuration, and keratinized mucosa width) were recorded after PICF sampling. Data was collected once for controls, and at baseline and 3 months post-treatment for test groups. Biomarker levels were analyzed using ELISA.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Having been using implant-supported fixed prostheses for more than 1 year. Radiographically, eligible implants were required to present a bone loss of ≥3 mm, accompanied by a clinical probing pocket depth (PPD) of 6-9 mm for peri-implantitis patients.
Exclusion Criteria:
The exclusion criteria were defined as follows: the presence of any systemic disease, particularly uncontrolled diabetes, uncontrolled hypertension, or severe cardiac conditions; current pregnancy or lactation; history of smoking or use of other tobacco products; and systemic conditions or long-term medication use known to affect bone metabolism, such as , bisphosphonates, or a history of radiotherapy. Additionally, individuals who had received antibiotic or antimicrobial therapy for any reason within the preceding 6 months, those who had undergone prior periodontal or peri-implant therapy before the commencement of the study, and individuals under 18 years of age or unwilling to provide were excluded from the study. In addition, mobil implants, implants previously subjected to surgical treatment for peri-implantitis, and implants for which reliable probing measurements could not be obtained were excluded from the analysis.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Air-polishing devices (APDs) + non-surgical treatment (NST)
Device: air-polishing devices
Only non-surgical treatment (NST)
Other: non-surgical treatment
healthy implants
Other: healthy implant
Subgingival air polishing performed using erythritol powder with an air-polishing device
Also known as: Airflow Master Piezon®, EMS
only non-surgical treatment
Individuals with peri-implant and periodontal health and clinically healthy implants
Plaque Index
to assess plaque accumulation
Time frame: Baseline
Plaque Index
to assess plaque accumulation
Time frame: 3 months post-treatment
Gingival Index
for evaluating gingival inflammation
Time frame: Baseline
Gingival Index
for evaluating gingival inflammation
Time frame: 3 months post-treatment
Probing pocket depth
for measuring disease severity
Time frame: Baseline
Probing pocket depth
for measuring disease severity
Time frame: 3 months post-treatment
Bleeding on Probing
to assess disease activity
Time frame: Baseline
Bleeding on Probing
to assess disease activity
Time frame: 3 months post-treatment
Radiographic Bone Level
RBL was determined by measuring, in millimeters, the distance between the implant neck/reference point and the marginal bone level at the mesial and distal aspects of each implant. The mean of the mesial and distal measurements was calculated to obtain the overall RBL value for each implant
Time frame: Baseline
Radiographic Bone Level
RBL was determined by measuring, in millimeters, the distance between the implant neck/reference point and the marginal bone level at the mesial and distal aspects of each implant. The mean of the mesial and distal measurements was calculated to obtain the overall RBL value for each implant
Time frame: 3 months post-treatment
Suppuration on Probing
Suppuration on Probing (SoP) to determine the presence or absence of purulent discharge from the peri-implant sulcus
Time frame: Baseline
Suppuration on Probing
Suppuration on Probing (SoP) to determine the presence or absence of purulent discharge from the peri-implant sulcus
Time frame: 3 months post-treatment
Keratinized Mucosa Width
Keratinized Mucosa Width (KMW) to assess the width of the keratinized mucosa around the implants
Time frame: Baseline
Keratinized Mucosa Width
Keratinized Mucosa Width (KMW) to assess the width of the keratinized mucosa around the implants
Time frame: 3 months post-treatment
IL-1β
IL-1β levels in peri-implant crevicular fluid (PICF)
Time frame: Baseline
IL-1β
IL-1β levels in peri-implant crevicular fluid (PICF)
Time frame: 3 months post-treatment
TNF-α
TNF-α levels in peri-implant crevicular fluid (PICF)
Time frame: Baseline
TNF-α
TNF-α levels in peri-implant crevicular fluid (PICF)
Time frame: 3 months post-treatment
IL-8
IL-8 levels in peri-implant crevicular fluid (PICF)
Time frame: Baseline
IL-8
IL-8 levels in peri-implant crevicular fluid (PICF)
Time frame: 3 months post-treatment
IL-36
IL-36 levels in peri-implant crevicular fluid (PICF)
Time frame: Baseline
IL-36
IL-36 levels in peri-implant crevicular fluid (PICF)
Time frame: 3 months post-treatment
Plan to share: No
No publications or documents are linked to this record.
Ran from Sep 2025 to primary completion in Dec 2025, 3 months.
Of 121 non-industry interventional studies with no phase under Peri-Implantitis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 46. This study's 3 months is below that.
Counting every sponsor, half of 128 studies reached it within 26 months; a quarter within 12 and three quarters within 40.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ordu University